Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Nukkleus Added to Russell Microcap Index
-
TruGolf Announces Portable Launch Monitor, LaunchBox, Available Globally on July 1st
-
Navigator Gas (NVGS) Joins the Russell 3000 and Russell 2000 Indexes
-
Dimensional Fund Advisors Ltd. : Form 8.3 - EMPIRIC STUDENT PROPERTY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AVIVA PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares
-
Accredited Investors: Navigating the Post-Pandemic Landscape
-
Ashvattha Therapeutics Presents Positive Interim Phase 2 Results for Subcutaneous Migaldendranib Treatment for DME and Wet-AMD at 2025 MaculArt Meeting
-
HighPeak Energy, Inc. Announces Proposed Aggregate $725 Million Private Offering of Senior Notes
-
Kneat Announces Upcoming Change to its Senior Leadership
-
Abacus Global Management Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants
-
23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation
-
Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings
-
Transom-Backed Secur-Serv Completes Fifth Add-On Acquisition, Delivers M&A Growth Story
-
LogicFlo raises $2.7M to arm every life sciences expert with their own AI workforce
-
Garrett Motion added to Russell 2000® Index
-
SunPower Joins the Russell 3000 & Russell Microcap Indices
-
CRISPR Therapeutics Named to TIME’s Most Influential Companies List of 2025
-
Kratos Defense & Security Solutions, Inc. Announces Completion of Public Offering of $575 Million of Common Stock at $38.50 Per Share
-
Refined Energy Corp Files 43-101 Report, Drill Program Recommended
-
Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
-
Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
-
NV5 Awarded $20 Million in New York City Park Facilities Design and Construction Management Contracts
-
Bonx raises $8.6 million to champion European manufacturing with market-leading AI ERP
-
Redwood Logistics Showcases OTM, WMS & GTM Integrations at Oracle OTM SIG 2025
-
Genius Group Board appoints Kevin Malone as Board Advisor.
-
Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment
-
Tokyo Lifestyle Co., Ltd.’s Hong Kong Subsidiary Signs HK$100 Million Strategic Revolving Loan Facility to Fuel Global Expansion
-
WTW and Verisk collaborate to boost efficiency, speed, accuracy, and analytical sophistication in commercial insurance pricing
-
Ferroglobe PLC Joins the Russell 2000® and Russell 3000® Indexes
-
Uni-Fuels Strengthens Asian Market Presence with A New Office in Shanghai
-
Volato Sells GC Aviation for $2 Million, Strengthening Focus on Scalable Platform Growth
-
Go-Ahead Group and BetterFleet Launch Europe’s Largest EV Charge Management Deployment
-
SunPower Joins the Russell 3000 & Russell Microcap Indices
-
Aimfinity Investment Corp. I Announces New Monthly Extension for Business Combination
-
Kratos Defense & Security Solutions, Inc. Announces Completion of Public Offering of $575 Million of Common Stock at $38.50 Per Share
-
Apollo Announces Olympus Housing Capital
-
Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement
-
Amaero Appoints Brett Paduch as Chief Financial Officer
-
Catheter Precision, Inc. Forms new Joint Venture Called Kardionav to Exploit patented AI Techniques to Create New VT Software platform
-
Heartflow to Showcase Landmark DECIDE Data at SCCT 2025, Advancing AI-Driven Care for Coronary Artery Disease
-
Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China
-
Spectral AI Announces Submission to FDA of its DeepView® System
-
Transom-Backed Secur-Serv Completes Fifth Add-On Acquisition, Delivers M&A Growth Story
-
Chemomab Announces Oral Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis at BSG Live’25
-
HealthLynked Appoints Andrew Mavliev as Chief Technology and Product Officer to Accelerate Direct-to-Consumer Healthcare Innovation
-
Tectonic Therapeutic Joins Russell 3000® Index
-
Freshworks Launches Freshservice Journeys to Make Work Life Easier by Removing Frustration from Employee Experiences
-
Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI-1179
